Navigation Links
WuXi PharmaTech Announces First-Quarter 2010 Results
Date:5/11/2010

6,209 4,239 Total current liabilities 66,832 80,337 Non-current liabilities: Long-term debt, excluding current portion 2,051 2,115 Advanced subsidies 1,333 1,420 Convertible notes 35,864 35,864 Other non-current liabilities 7,544 7,432 Total non-current liabilities 46,792 46,831 Total liabilities 113,624 127,168 Shareholders' equity: Ordinary shares ($0.02 par value, 5,002,550,000 authorized, 554,443,600 and 550,609,256 issued and outstanding as of March 31, 2010, and December 31, 2009, respectively) 11,089 11,012 Additional paid-in capital 323,024 320,672 Accumulated deficit (53,114) (68,631) Accumulated other comprehensive income 17,150 17,080 Total shareholders' equity 298,149 280,133 Total liabilities and shareholders' equity 411,773 407,301 WUXI PHARMATECH (CAYMAN) INC. UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands of U.S. dollars, except ADS data and per ADS data) Three Months Ended March 31, 2010 2009 % Change Net revenues: Laboratory Services 66,998 56,596 18% Manufacturing Services 13,604 2,552 433% Total net revenues 80,602 59,148 36% Cost of revenues: Laboratory Serv
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
2. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
3. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
4. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
5. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
6. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
7. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
8. CrystalGenomics Announces Successful Completion of a Phase I SAD Clinical Trial for CG400549, its Novel Antibiotic Candidate
9. Jazz Pharmaceuticals Announces Public Offering of Common Stock
10. Epix Pharmaceuticals, Inc. Announces Additional Information Concerning the May 28, 2010 Auction Sale of EP-2104R MRI Imaging Agent
11. Somanetics Corporation Announces 24 Clinical Abstracts on INVOS System Presented at Annual Pediatric Academic Societies National Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... -- Talyst, a market leader in pharmacy automation will be ... Nashville, TN. The company will be ... onsite, remote medication dispensing. Talyst,s InSite ... securely dispense medication onsite, on demand. Remote dispensing cuts ... the correct medication gets to the correct patient in ...
(Date:10/17/2014)...   InnFocus, Inc ., reported on results of 59 ... for up to 3 years with the InnFocus MicroShunt® ... Chicago . The Summit ... of the American Academy of Ophthalmology . The Company ... patients in 6 countries by early 2015. Logo ...
(Date:10/17/2014)... , Oct. 17, 2014  China Biologic Products, ... a leading fully integrated plasma-based biopharmaceutical company in ... the Company has received approval from the China ... manufacturing of human prothrombin complex concentrate ("PCC") at ... Taibang,s new coagulation factor production facility for Good ...
Breaking Medicine Technology:Talyst Exhibits at LeadingAge Annual Meeting 2InnFocus Featured at the Ophthalmology Innovation Summit In Chicago 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
... 14, 2011 mBeach Software Inc. ("MBHS") (MBHS.PK), the ... today that on Dec. 13, 2011 it entered into ... of IRIS Marketing Ltd., an Israeli company, that has ... facto merger of IRIS Marketing with mBeach, when concluded, ...
... Consumer Healthcare Products Association (CHPA) President and CEO Scott ... the 2011 National Institute on Drug Abuse,s (NIDA,s) Monitoring ... medicine abuse among twelfth graders has decreased by 1.2 ... tenth graders remained stable, at 2.7 and 5.5 percent ...
Cached Medicine Technology:mBeach Software Inc. to Acquire a Controlling Interest in IRIS Marketing Ltd. 2Statement from the Consumer Healthcare Products Association (CHPA) on Annual Monitoring the Future Survey on Drug Abuse 2
(Date:10/20/2014)... Dunbridge, Ohio (PRWEB) October 20, 2014 ... 50 years, takes pride in manufacturing top-of-the-line absorbent products. ... the image of its most popular brand, Tranquility® Premium ... logo, created a new website, gave its packaging a ... to bring the brand message to the public. , ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
(Date:10/20/2014)... Silver Spring, Maryland, USA (PRWEB) October 20, 2014 ... readers or to track interventions? Here comes a wonderful ... leading mobile app development company helped its ... track Intervention more efficiently. The app is designed for ... iPad, and iPod touch. This app is optimized for ...
(Date:10/19/2014)... October 19, 2014 Dr. Babatunde Osotimehin, ... welcomes news of a ceasefire agreement that is expected ... 200 girls who were kidnapped from the north-eastern Nigerian ... in captivity long enough, and it is high time ... stated Dr. Osotimehin. , "We owe it to these ...
Breaking Medicine News(10 mins):Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 2Health News:Metassessor App Launched: an RTI tool for Teachers & Parents 3
... worldwide as the standard of care for a serious lung ... should not be used together to treat the disease, called ... rigorous independent study. The study, which will appear online ... to coincide with a presentation at the annual meeting ...
... Rosenfeld, M.D., M.P.H., of Seattle Children,s Hospital, and colleagues conducted ... rate of pulmonary exacerbations in children younger than 6 years ... recommended as therapy for patients 6 years or older with ... younger than 6 years. In the randomized trial, the ...
... obstructive sleep apnea (OSA) in children normalizes disturbances in ... according to a new study. "OSA is ... and executive function," said lead author Ann Halbower, MD, ... University of Colorado Denver. "Our study is the first ...
... Preliminary results from an ongoing, large-scale study by Yale ... naturally occurring substance produced in the brain and throughout ... known to process social information in children and adolescents ... Child Study Center research team that includes postdoctoral fellow ...
... News) -- Female athletes take longer to recover from ... have longer recovery times. The findings show that doctors ... into account when treating patients with concussions, said researchers ... from nearly 300 athletes in the United States who ...
... News) -- Older men have an increased risk of developing ... not know how to properly check themselves for signs of ... worrisome because nearly 132,000 new cases of melanoma will be ... which conducted the online poll. "This survey demonstrates that ...
Cached Medicine News:Health News:First, do no harm: Study finds danger in standard treatment for a serious lung disease 2Health News:First, do no harm: Study finds danger in standard treatment for a serious lung disease 3Health News:Treatment of childhood OSA reverses brain abnormalities 2Health News:Oxytocin improves brain function in children with autism 2Health News:Females, Young Athletes Take Longer to Get Over Concussions 2Health News:Melanoma a Big Threat to Older Men 2
... is a modular orthotic elbow system that can ... distal humeral fractures, proximal ulnar fractures or post ... K2 is a highly flexible system that provides ... assemble the brace that best fits your patients ...
The IROM Elbow is ideal for fixed or controlled ROM in the treatment of stable supracondylar fractures, stable radial fractures, and lateral/medial epicondylitis....
A lightweight soft good with rigid elbow protection. Designed by medical professionals with your needs in mind. Provides elbow stability for mild to moderate medial/lateral and hyperextension injurie...
Innovative support that immobilizes and positions elbow at 122 to minimize stretching of ulnar nerve...
Medicine Products: